163 related articles for article (PubMed ID: 766806)
1. Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata.
Currie GA; Eccles SA
Br J Cancer; 1976 Jan; 33(1):51-9. PubMed ID: 766806
[TBL] [Abstract][Full Text] [Related]
2. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
Mendiondo O; Suit H; Fixler H
Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
[No Abstract] [Full Text] [Related]
3. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
Parr IB; Wheeler LE; Alexander P
Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
[TBL] [Abstract][Full Text] [Related]
4. Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma.
Currie GA
Br J Cancer; 1976 Jun; 33(6):593-9. PubMed ID: 938609
[TBL] [Abstract][Full Text] [Related]
5. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
Ghaffar A; Cullen RT; Woodruff MA
Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
Moore M; Lawrence N; Nisbet NW
Biomedicine; 1976 Jan; 24(1):26-31. PubMed ID: 773443
[TBL] [Abstract][Full Text] [Related]
7. Rate of tumour inhibition by activated macrophages in vitro.
Orinda DA
East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
[No Abstract] [Full Text] [Related]
8. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
Miyata H; Himeno K; Miake S; Nomoto K
Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
[TBL] [Abstract][Full Text] [Related]
9. Macrophages and lymphoid tissues in mice with concomitant tumour immunity.
Nelson DS; Kearney R
Br J Cancer; 1976 Sep; 34(3):221-6. PubMed ID: 973997
[TBL] [Abstract][Full Text] [Related]
10. Host responses in adjuvant contact suppression of experimental rat tumours.
Pimm MV; Hopper DG; Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():349-54. PubMed ID: 344098
[TBL] [Abstract][Full Text] [Related]
11. The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.
Alexander P; Bensted J; Delorme EJ; Hall JG; Hodgett J
Proc R Soc Lond B Biol Sci; 1969 Nov; 174(1035):237-51. PubMed ID: 4391182
[No Abstract] [Full Text] [Related]
12. Tumour inhibition mediated by BCG in immunosuppressed rats.
Moore M; Lawrence N; Nisbet NW
Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
[TBL] [Abstract][Full Text] [Related]
13. The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.
McBride WH; Tuach S; Marmion BP
Br J Cancer; 1975 Nov; 32(5):558-67. PubMed ID: 813755
[TBL] [Abstract][Full Text] [Related]
14. Abnormal lysozyme production of peritoneal macrophages from mastocytoma P-815 bearing C3D2F1-mice.
Bandlow G; Kühne J
Med Microbiol Immunol; 1980 Feb; 168(1):55-62. PubMed ID: 6770238
[TBL] [Abstract][Full Text] [Related]
15. Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.
Szymaniec S; James K
Br J Cancer; 1976 Jan; 33(1):36-50. PubMed ID: 1252329
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
17. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
Palladino MA; Thorbecke GJ
Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
[No Abstract] [Full Text] [Related]
18. Influence of whole body irradiation on bcg contact suppression of a rat sarcoma and tumour-specific immunity.
Pimm MV; Baldwin RW
Br J Cancer; 1976 Aug; 34(2):199-202. PubMed ID: 986827
[No Abstract] [Full Text] [Related]
19. Monocytosis associated with the growth of transplanted syngeneic rat sarcomata differing in immunogenicity.
Eccles SA; Bandlow G; Alexander P
Br J Cancer; 1976 Jul; 34(1):20-7. PubMed ID: 952713
[TBL] [Abstract][Full Text] [Related]
20. BCG immunotherapy of rat tumors of defined immunogenicity.
Baldwin RW; Pimm MV
Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
